Sweet Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.68M Sell
8,307
-872
-9% -$285K 0.58% 38
2024
Q2
$2.87M Sell
9,179
-23
-0.2% -$6.76K 0.66% 31
2024
Q1
$2.62M Sell
9,202
-4,212
-31% -$1.23M 0.6% 36
2023
Q4
$3.86M Buy
13,414
+279
+2% +$76K 0.92% 16
2023
Q3
$3.53M Buy
13,135
+235
+2% +$58.6K 0.93% 17
2023
Q2
$2.86M Buy
12,900
+3,094
+32% +$718K 0.75% 19
2023
Q1
$2.37M Buy
9,806
+4,132
+73% +$1.01M 0.66% 24
2022
Q4
$1.49M Sell
5,674
-40
-0.7% -$10.7K 0.44% 34
2022
Q3
$1.29M Sell
5,714
-1,728
-23% -$419K 0.41% 33
2022
Q2
$1.81M Buy
7,442
+2,511
+51% +$615K 0.57% 28
2022
Q1
$1.19M Buy
4,931
+1,510
+44% +$347K 0.32% 38
2021
Q4
$770K Buy
+3,421
New +$722K 0.32% 45

Other funds holding AMGN

Sweet Financial Partners's AMGN Position: Q3 2024 in Review

Sweet Financial Partners reduced its Amgen (AMGN) stake by 9.5% in Q3 2024, selling an estimated $285K and leaving 8,307 shares worth $2.68M. The position accounts for 0.58% of the portfolio, ranked #38.

Sweet Financial Partners first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. The position peaked at $3.86M in Q4 2023. 2,828 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Sweet Financial Partners held 8,307 shares of Amgen worth $2.68M as of Q3 2024.
  • Sweet Financial Partners sold 872 Amgen shares in Q3 2024, an estimated $285K.
  • Amgen made up 0.58% of Sweet Financial Partners's portfolio in Q3 2024, its #38 holding.
  • Sweet Financial Partners first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • Sweet Financial Partners's Amgen position peaked at $3.86M in Q4 2023.
  • 2,828 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Sweet Financial Partners's 13F filing for Q3 2024, filed 16 Oct 2024.